| Home | E-Submission | Sitemap | Contact Us |  
     
ORIGINAL ARTICLE 2018 January 20
The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
1. Fecal calprotectin (FC) level was strongly associated with disease activity indices, serologic markers, and endoscopic activity in patients with inflammatory bowel disease. 2. In particular, calprotectin assays could predict mucosal healing with high sensitivity (> 81%) and specificity (100%) in ulcerative colitis patients. Therefore, FC may be a useful alternative to repeated endoscopies. 3. Quantitative point-of care test can be used more conveniently than enzyme-linked immunosorbent assay to assess FC in clinical practice.
ORIGINAL ARTICLE 2017 November 29
Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease
1. The IBD-KNOW (Inflammatory Bowel Disease Knowledge), a novel assessment tool of inflammatory bowel disease (IBD)-related knowledge, demonstrated excellent test characteristics compared with outdated Crohn’s and Colitis Knowledge score. 2. Hospitalization history, education level, and information acquired from patient organization play an important role in correct IBD-related knowledge.
ORIGINAL ARTICLE 2017 November 27
Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
1. Olmesartan use does not increase the risk of intestinal malabsorption in the general Korean population compared to angiotensin converting enzyme (ACE) inhibitor use. 2. Olmesartan use was not associated with the significant body weight loss in the general Koean population compared to ACE inhibitor use.
ORIGINAL ARTICLE 2018 April 4
Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators
1. Our single-center study demonstrated the safety of pacemakers or implantable cardioverter defibrillators for 1.5-T magnetic resonance imaging (MRI) scans regardless of whether magnetic resonance-conditional or conventional devices were used. 2. Despite the small study population, our study enrolled variable cases representative of real clinical practice, such as cases of MRI being performed more than twice and performed without mode changes
ORIGINAL ARTICLE 2018 June 14
Nonpulmonary risk factors of acute respiratory distress syndrome in patients with septic bacteraemia
1. Among nonpulmonary organ dysfunctions, central nervous system dysfunction and coagulopathy were independent risk factors for the development of acute respiratory distress syndrome (ARDS) in patients with bacteremia sepsis. 2. The development of ARDS was significantly associated with an increase in 28-day mortality in patients with bacteremic sepsis.
Volume34 No. 1
Current Issue
Volume 34(1); January 2019
RSS feed
This archive contains links to the full-text of all issues of Korean J Intern Med.
Current Issue
Volume 34, No 1
Past Issues
Vol.33
2018
v.33(1)
Jan 2018
v.33(2)
Mar 2018
v.33(3)
May 2018
v.33(4)
Jul 2018
v.33(5)
Sep 2018
v.33(6)
Nov 2018
Vol.32
2017
v.32(1)
Jan 2017
v.32(2)
Mar 2017
v.32(3)
May 2017
v.32(4)
Jul 2017
v.32(5)
Sep 2017
v.32(6)
Nov 2017
Vol.31
2016
v.31(1)
Jan 2016
v.31(2)
Mar 2016
v.31(3)
May 2016
v.31(4)
Jul 2016
v.31(5)
Sep 2016
v.31(6)
Nov 2016
Vol.30
2015
v.30(1)
Jan 2015
v.30(2)
Mar 2015
v.30(3)
May 2015
v.30(4)
Jul 2015
v.30(5)
Sep 2015
v.30(6)
Nov 2015
Vol.29
2014
v.29(1)
Jan 2014
v.29(2)
Mar 2014
v.29(3)
May 2014
v.29(4)
Jul 2014
v.29(5)
Sep 2014
v.29(6)
Nov 2014
Vol.28
2013
v.28(1)
Jan 2013
v.28(2)
Mar 2013
v.28(3)
May 2013
v.28(4)
Jul 2013
v.28(5)
Sep 2013
v.28(6)
Nov 2013
Vol.27
2012
v.27(1)
Mar 2012
v.27(2)
Jun 2012
v.27(3)
Sep 2012
v.27(4)
Dec 2012
Vol.26
2011
v.26(1)
Mar 2011
v.26(2)
Jun 2011
v.26(3)
Sep 2011
v.26(4)
Dec 2011
Vol.25
2010
v.25(1)
Mar 2010
v.25(2)
Jun 2010
v.25(3)
Sep 2010
v.25(4)
Dec 2010
Vol.24
2009
v.24(1)
Mar 2009
v.24(2)
Jun 2009
v.24(3)
Sep 2009
v.24(4)
Dec 2009
Vol.23
2008
v.23(1)
Mar 2008
v.23(2)
Jun 2008
v.23(3)
Sep 2008
v.23(4)
Dec 2008
Vol.22
2007
v.22(1)
Mar 2007
v.22(2)
Jun 2007
v.22(3)
Sep 2007
v.22(4)
Dec 2007
Vol.21
2006
v.21(1)
Mar 2006
v.21(2)
Jun 2006
v.21(3)
Sep 2006
v.21(4)
Dec 2006
Vol.20
2005
v.20(1)
Mar 2005
v.20(2)
Jun 2005
v.20(3)
Sep 2005
v.20(4)
Dec 2005
Vol.19
2004
v.19(1)
Mar 2004
v.19(2)
Jun 2004
v.19(3)
Sep 2004
v.19(4)
Dec 2004
Vol.18
2003
v.18(1)
Mar 2003
v.18(2)
Jun 2003
v.18(3)
Sep 2003
v.18(4)
Dec 2003
Vol.17
2002
v.17(1)
Mar 2002
v.17(2)
Jun 2002
v.17(3)
Sep 2002
v.17(4)
Dec 2002
Vol.16
2001
v.16(1)
Mar 2001
v.16(2)
Jun 2001
v.16(3)
Sep 2001
v.16(4)
Dec 2001
Vol.15
2000
v.15(1)
Jan 2000
v.15(2)
Jul 2000
v.15(3)
Dec 2000
Vol.14
1999
v.14(1)
Jan 1999
v.14(2)
Jul 1999
Vol.13
1998
v.13(1)
Jan 1998
v.13(2)
Jul 1998
Vol.12
1997
v.12(1)
Jan 1997
v.12(2)
Jul 1997
Vol.11
1996
v.11(1)
Jan 1996
v.11(2)
Jul 1996
Vol.10
1995
v.10(1)
Jan 1995
v.10(2)
Jul 1995
Vol.9
1994
v.9(1)
Jan 1994
v.9(2)
Jul 1994
Vol.8
1993
v.8(1)
Jan 1993
v.8(2)
Jul 1993
Vol.7
1992
v.7(1)
Jan 1992
v.7(2)
Jul 1992
Vol.6
1991
v.6(1)
Jan 1991
v.6(2)
Jul 1991
Vol.5
1990
v.5(1)
Jan 1990
v.5(2)
Jul 1990
Vol.4
1989
v.4(1)
Jan 1989
v.4(2)
Jul 1989
Vol.3
1988
v.3(1)
Jan 1988
v.3(2)
Jul 1988
Vol.2
1987
v.2(1)
Jan 1987
v.2(2)
Jul 1987
Vol.1
1986
v.1(1)
Jan 1986
v.1(2)
Jul 1986
Author's Index
Impact factor
SCImago Journal & Country Rank
crossref CITEDBY
CrossMark
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
Copyright © 2019 The Korean Association of Internal Medicine. All rights reserved.
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
powerd by m2community